Characteristics of Benign Lesions
| Visual uptake grading | ||||
|---|---|---|---|---|
| Patient no. | Diagnosis | US* | XMM† | SMM‡ |
| 10 | Fibrocystic changes, other (fat) | No lesion | No lesion | 2 |
| 13 | Fibrocystic changes | 2 | 2 | 1 |
| 17 | 4 Fibrocystic changes | 2 | 2 | 2 (FNAC)§, 3 others |
| 18 | Fibroadenoma | 2 | 2 | 1 |
| 19 | Infectious cyst | 2 | 2 | 3 |
| 20 | Fibroadenoma | 3 | 2 | 1 |
↵* US: 5-scale grading, where grade 2 = benign finding and grade 3 = indeterminate.
↵† XMM: findings are graded according to BIRADS, where grade 1 = negative, grade 2 = benign finding, grade 3 = probably benign finding, grade 4 = suspicious abnormality (biopsy should be considered), and grade 5 = highly suggestive of malignancy.
↵‡ SMM with NC100692 administration (study drug): 3-grade scale, where grade 1 = no obvious uptake, grade 2 = uncertain/heterogeneous uptake, and grade 3 = focal lesion uptake.
↵§ FNAC = lesion had fine-needle aspiration cytology before scintigraphy.
BIRADS = Breast Imaging Reporting and Data System.